JOSE RAMON
BILBAO CATALA
PROFESORADO PLENO
Department: Genética, Antropología Física y Fisiología Animal
Centre: Facultad de Medicina y Enfermería
Campus: Bizkaia
Field of knowledge: Ciencias de la Salud
Area: Genetics
Research group: Grupo de Investigación de Endocrinología, Diabetes, Nutrición, alteraciones Renales y Salud Infantil - GIC 21/144
Email: joseramon.bilbao@ehu.eus
Doctor by the Universidad del País Vasco - Euskal Herriko Unibertsitatea with the thesis Autoinmunidad humoral en la diabetes tipo 1 marcadores serológicos en el diagnóstico precoz 2000. Supervised by Dr. Luis Castaño González.
José Ramón Bilbao Catalá is Full Professor of Medical Genetics at the UPV/EHU since 2023 and PI at the IIS Biobizkaia. He holds a PhD in Biology from the UPV/EHU, and was trained in Microbiology, Immunology and Genetics at institutions such as the University of Leicester (UK) and the Barbara Davis Center for Diabetes (CO-USA). He was awarded a Miguel Servet contract at as Cruces University Hospital in 2000 and has maintained continuous funding from the National Plan (6 ISCIII projects and 1 from the MCI) and the Basque Government (9 projects). It has 4 research sections and 3 teaching sections. He has published more than 100 international articles with an h-index of 32 and has supervised 15 doctoral theses, 8 of which are international. His research focuses on functional elements of genomic regions associated with autoimmune diseases, especially celiac disease, combining omics technologies (GWAS, RNA-Seq, methylation) and bioinformatic approaches. He has coordinated the CEGEC consortium and participated in international initiatives such as Immunochip. In addition, she leads the genomics of the INMA-Gipuzkoa cohort, studying genetic and epigenetic variations linked to environmental exposure and their impact on child development. He investigates molecular phenotypes that connect genetic susceptibility with complex pathologies through catalogs of mQTLs and eQTLs in saliva and placenta, looking for markers and therapeutic targets.